Anaphylaxis: assessment and referral after emergency treatment: Draft for consultation
Open for comments Open until Request commenting lead permission
We have updated this service so that members of the same organisation can now collaborate on a joint online response.
Read our blog to learn more.
Update information
January 2026: The recommendations on period of observation have been updated to reflect the Resuscitation Council UK's emergency treatment of anaphylaxis 2021 guideline (section 8.2). Recommendation 1.4.1 has been amended to clarify our advice on admitting children. Recommendation 1.4.3 has been amended to bring it in line with the Medicines and Healthcare products Regulatory Agency (MHRA) guidance about safe use of adrenaline auto-injectors, and Resuscitation Council UK guidance (section 8.6) and BSACI guidance on adrenaline auto-injector prescription for patients at risk of anaphylaxis. Recommendation1.5.1 has been amended to clarify our advice on adrenaline auto-injectors.
August 2020: Advice was added to recommendation 1.5.1 that people should be offered a prescription for 2 further adrenaline auto-injectors before discharge and advised to carry these with them at all times.
Minor changes after publication
December 2021: We updated our advice in recommendation 1.5.1 on the information people should be given about using their adrenaline auto-injector, in line with advice from the MHRA.
ISBN: 978-1-4731-3867-4
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions